Madison Avenue Partners’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Madison Avenue Partners’s Portfolio MACK Stock Details MACK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-387,221	Closed	-$5.72M	–	24
2024 Q1	$5.72M	Sell	387,221 -165,864	-30%	-$2.33M	0.92%	14
2023 Q4	$7.42M	Hold	553,085	–	–	1.05%	14
2023 Q3	$6.82M	Hold	553,085	–	–	0.97%	10
2023 Q2	$6.8M	Hold	553,085	–	–	1.48%	11
2023 Q1	$6.8M	Buy	+553,085	New	+$6.5M	1.46%	14

Other funds holding MACK

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Rise Advisors Rochester, New York $355M AUM 20.51% 1-Year Est. Return

JBF Capital Aspen, Colorado $764M AUM 24.26% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Madison Avenue Partners's MACK Position: Q2 2024 in Review

Madison Avenue Partners sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q2 2024, closing a stake of 387,221 shares — an estimated $5.72M sold.

Madison Avenue Partners first reported a position in MACK in Q1 2023 and held it in 5 quarters. The position peaked at $7.42M in Q4 2023. 12 funds tracked by Wall St. Rank hold MACK as of Q2 2024.

Madison Avenue Partners reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q2 2024 after selling out during the quarter.
Madison Avenue Partners sold 387,221 Merrimack Pharmaceuticals, Inc. shares in Q2 2024, an estimated $5.72M.
Madison Avenue Partners first reported a position in Merrimack Pharmaceuticals, Inc. in Q1 2023 and held it in 5 quarters.
Madison Avenue Partners's Merrimack Pharmaceuticals, Inc. position peaked at $7.42M in Q4 2023.
12 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q2 2024.

Based on Madison Avenue Partners's 13F filing for Q2 2024, filed 14 Aug 2024.